Skip to main content
SpringerLink
Log in
Book cover

Chikungunya Virus pp 161–183Cite as

Chikungunya Virus Pathogenesis

  • Chapter
  • First Online:

  • 1045 Accesses

Abstract

Chikungunya virus (CHIKV) is a re-emerging mosquito-transmitted alphavirus. Following inoculation into the skin, CHIKV replicates locally and ultimately produces a high titer viremia that facilitates a human–mosquito–human transmission cycle. Symptoms and signs of CHIKV infection include high fever, severe joint pain, muscle pain, and rash. The acute phase of CHIKV infection typically lasts a few days to a couple of weeks. In many individuals, the musculoskeletal pain and inflammation associated with acute CHIKV infection becomes chronic and may last for months to years. In addition, atypical outcomes of CHIKV infection, including neurological involvement and death, can occur in the elderly, the young, and in the presence of certain comorbidities.

The pathogenesis of acute and chronic CHIKV disease is not well understood. However, the dramatic re-emergence and global spread of CHIKV during the last 10 years has resulted in new investigations of CHIKV biology and pathogenesis in humans and animal models. In this chapter, we present the most recent advances in our understanding of acute and chronic CHIKV pathogenesis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Akhrymuk I, Kulemzin SV, Frolova EI (2012) Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II. J Virol 86(13):7180–7191. doi:10.1128/JVI.00541-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ashbrook AW, Burrack KS, Silva LA, Montgomery SA, Heise MT, Morrison TE, Dermody TS (2014) Residue 82 of the chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice. J Virol 88(21):12180–12192. doi:10.1128/JVI.01672-14

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ayu SM, Lai LR, Chan YF, Hatim A, Hairi NN, Ayob A, Sam IC (2010) Seroprevalence survey of chikungunya virus in Bagan Panchor, Malaysia. Am J Trop Med Hyg 83(6):1245–1248. doi:10.4269/ajtmh.2010.10-0279

    Article  PubMed  PubMed Central  Google Scholar 

  • Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Becquart JP, Wengling C, Michault A, Paganin F (2007) Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 44(11):1401–1407. doi:10.1086/517537

    Article  PubMed  Google Scholar 

  • Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F (2008) Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis 47(4):469–475. doi:10.1086/590003

    Article  PubMed  Google Scholar 

  • Brighton S, Prozesky O, De La Harpe A (1983) Chikungunya virus infection: a retrospective of 107 cases. S Afr Med J 63(9):313–315

    CAS  PubMed  Google Scholar 

  • Chen CI, Clark DC, Pesavento P, Lerche NW, Luciw PA, Reisen WK, Brault AC (2010) Comparative pathogenesis of epidemic and enzootic chikungunya viruses in a pregnant Rhesus macaque model. AmJTrop Med Hyg 83(6):1249–1258. doi:10.4269/ajtmh.2010.10-0290

    Article  Google Scholar 

  • Chen W, Foo SS, Rulli NE, Taylor A, Sheng KC, Herrero LJ, Herring BL, Lidbury BA, Li RW, Walsh NC, Sims NA, Smith PN, Mahalingam S (2014a) Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. Proc Natl Acad Sci U S A 111(16):6040–6045. doi:10.1073/pnas.1318859111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen W, Foo SS, Taylor A, Lulla A, Merits A, Hueston L, Forwood MR, Walsh NC, Sims NA, Herrero LJ, Mahalingam S (2014b) Bindarit, an inhibitor of monocyte chemotactic proteins (MCPs) synthesis, protects against bone loss induced by chikungunya virus infection. J Virol 89(1):581–593. doi:10.1128/JVI.02034-14

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chow A, Her Z, Ong EK, Chen JM, Dimatatac F, Kwek DJ, Barkham T, Yang H, Renia L, Leo YS, Ng LF (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203(2):149–157. doi:10.1093/infdis/jiq042

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coffey LL, Beeharry Y, Borderia AV, Blanc H, Vignuzzi M (2011) Arbovirus high fidelity variant loses fitness in mosquitoes and mice. Proc Natl Acad Sci U S A 108(38):16038–16043. doi:10.1073/pnas.1111650108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Despres P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M (2008) A mouse model for chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 4(2), e29. doi:10.1371/journal.ppat.0040029

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S, Prost JF, Lecuit M (2009) Prophylaxis and therapy for chikungunya virus infection. J Infect Dis 200(4):516–523

    Article  CAS  PubMed  Google Scholar 

  • Couturier E, Guillemin F, Mura M, Leon L, Virion JM, Letort MJ, De Valk H, Simon F, Vaillant V (2012) Impaired quality of life after chikungunya virus infection: a 2-year follow-up study. Rheumatology 51(7):1315–1322. doi:10.1093/rheumatology/kes015

    Article  PubMed  Google Scholar 

  • Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P (2012) Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 6(3), e1446. doi:10.1371/journal.pntd.0001446

    Article  PubMed  PubMed Central  Google Scholar 

  • Edelman R, Tacket CO, Wasserman SS, Bodison SA, Perry JG, Mangiafico JA (2000) Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg 62(6):681–685

    CAS  PubMed  Google Scholar 

  • Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K (2013) Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J 89(1054):440–447. doi:10.1136/postgradmedj-2012-131477

    Article  PubMed  Google Scholar 

  • Fourie ED, Morrison JG (1979) Rheumatoid arthritic syndrome after chikungunya fever. S Afr Med J 56(4):130–132

    CAS  PubMed  Google Scholar 

  • Fraser JR, Cunningham AL, Clarris BJ, Aaskov JG, Leach R (1981) Cytology of synovial effusions in epidemic polyarthritis. Aust N Z J Med 11(2):168–173

    Article  CAS  PubMed  Google Scholar 

  • Fric J, Bertin-Maghit S, Wang CI, Nardin A, Warter L (2013) Use of human monoclonal antibodies to treat chikungunya virus infection. J Infect Dis 207(2):319–322. doi:10.1093/infdis/jis674

    Article  CAS  PubMed  Google Scholar 

  • Fros JJ, Liu WJ, Prow NA, Geertsema C, Ligtenberg M, Vanlandingham DL, Schnettler E, Vlak JM, Suhrbier A, Khromykh AA, Pijlman GP (2010) Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. J Virol 84(20):10877–10887. doi:10.1128/JVI.00949-10

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fros JJ, Domeradzka NE, Baggen J, Geertsema C, Flipse J, Vlak JM, Pijlman GP (2012) Chikungunya virus nsP3 blocks stress granule assembly by recruitment of G3BP into cytoplasmic foci. J Virol 86(19):10873–10879. doi:10.1128/JVI.01506-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gardner J, Anraku I, Le TT, Larcher T, Major L, Roques P, Schroder WA, Higgs S, Suhrbier A (2010) Chikungunya virus arthritis in adult wild-type mice. J Virol 84(16):8021–8032. doi:10.1128/JVI.02603-09

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gardner CL, Burke CW, Higgs ST, Klimstra WB, Ryman KD (2012) Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate. Virology 425(2):103–112. doi:10.1016/j.virol.2011.12.020

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gardner CL, Hritz J, Sun C, Vanlandingham DL, Song TY, Ghedin E, Higgs S, Klimstra WB, Ryman KD (2014) Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl Trop Dis 8(2), e2719. doi:10.1371/journal.pntd.0002719

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gerardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, Lenglet Y, Touret Y, Bouveret A, Grivard P, Le Roux K, Blanc S, Schuffenecker I, Couderc T, Arenzana-Seisdedos F, Lecuit M, Robillard P-Y (2008a) Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion. PLoS Med 5(3), e60

    Article  PubMed  PubMed Central  Google Scholar 

  • Gerardin P, Guernier V, Perrau J, Fianu A, Le Roux K, Grivard P, Michault A, de Lamballerie X, Flahault A, Favier F (2008b) Estimating chikungunya prevalence in La Reunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis 8:99. doi:10.1186/1471-2334-8-99

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gerardin P, Fianu A, Michault A, Mussard C, Bousaid K, Rollot O, Grivard P, Kassab S, Bouquillard E, Borgherini G, Gauzere BA, Malvy D, Breart G, Favier F (2013) Predictors of chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther 15(1), R9

    Article  PubMed  PubMed Central  Google Scholar 

  • Gerardin P, Samperiz S, Ramful D, Boumahni B, Bintner M, Alessandri JL, Carbonnier M, Tiran-Rajaoefera I, Beullier G, Boya I, Noormahomed T, Okoi J, Rollot O, Cotte L, Jaffar-Bandjee MC, Michault A, Favier F, Kaminski M, Fourmaintraux A, Fritel X (2014) Neurocognitive outcome of children exposed to perinatal mother-to-child chikungunya virus infection: the CHIMERE cohort study on Reunion Island. PLoS Negl Trop Dis 8(7), e2996. doi:10.1371/journal.pntd.0002996

    Article  PubMed  PubMed Central  Google Scholar 

  • Goh LY, Hobson-Peters J, Prow NA, Gardner J, Bielefeldt-Ohmann H, Pyke AT, Suhrbier A, Hall RA (2013) Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model. Clin Immunol 149(3):487–497. doi:10.1016/j.clim.2013.10.004

    Article  CAS  PubMed  Google Scholar 

  • Gorchakov R, Wang E, Leal G, Forrester NL, Plante K, Rossi SL, Partidos CD, Adams AP, Seymour RL, Weger J, Borland EM, Sherman MB, Powers AM, Osorio JE, Weaver SC (2012) Attenuation of chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol 86(11):6084–6096. doi:10.1128/JVI.06449-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, Fraser RJ, Herrero LJ, Ramirez R, Smith PN, Mahalingam S, Heise MT (2012) Mannose binding lectin is required for alphavirus-induced arthritis/myositis. PLoS Pathog 8(3), e1002586. doi:10.1371/journal.ppat.1002586

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, Morrison TE (2013) Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J Virol 87(24):13878–13888. doi:10.1128/JVI.02666-13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Her Z, Teng TS, Tan JJ, Teo TH, Kam YW, Lum FM, Lee WW, Gabriel C, Melchiotti R, Andiappan AK, Lulla V, Lulla A, Win MK, Chow A, Biswas SK, Leo YS, Lecuit M, Merits A, Renia L, Ng LF (2014) Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response. EMBO Mol Med 7(1):24–41. doi:10.15252/emmm.201404459

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Herrero LJ, Sheng KC, Jian P, Taylor A, Her Z, Herring BL, Chow A, Leo YS, Hickey MJ, Morand EF, Ng LF, Bucala R, Mahalingam S (2013) Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection. Arthritis Rheum 65(10):2724–2736. doi:10.1002/art.38090

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, Tallet F, Moiton MP, Gauzere BA, Bruniquet S, Jaffar Bandjee Z, Morbidelli P, Martigny G, Jolivet M, Gay F, Grandadam M, Tolou H, Vieillard V, Debre P, Autran B, Gasque P (2010) Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 184(10):5914–5927. doi:10.4049/jimmunol.0900255

    Article  CAS  PubMed  Google Scholar 

  • Hoarau JJ, Gay F, Pelle O, Samri A, Jaffar-Bandjee MC, Gasque P, Autran B (2013) Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island. PLoS One 8(12), e84695. doi:10.1371/journal.pone.0084695

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Holers VM (2014) Complement and its receptors: new insights into human disease. Annu Rev Immunol 32:433–459. doi:10.1146/annurev-immunol-032713-120154

    Article  CAS  PubMed  Google Scholar 

  • Kam YW, Lee WW, Simarmata D, Harjanto S, Teng TS, Tolou H, Chow A, Lin RT, Leo YS, Renia L, Ng LF (2012a) Longitudinal analysis of the human antibody response to chikungunya virus infection: implications for serodiagnosis and vaccine development. J Virol 86(23):13005–13015. doi:10.1128/JVI.01780-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kam YW, Lum FM, Teo TH, Lee WW, Simarmata D, Harjanto S, Chua CL, Chan YF, Wee JK, Chow A, Lin RT, Leo YS, Le Grand R, Sam IC, Tong JC, Roques P, Wiesmuller KH, Renia L, Rotzschke O, Ng LF (2012b) Early neutralizing IgG response to chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein. EMBO Mol Med 4(4):330–343. doi:10.1002/emmm.201200213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kam YW, Simarmata D, Chow A, Her Z, Teng TS, Ong EK, Renia L, Leo YS, Ng LF (2012c) Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis 205(7):1147–1154. doi:10.1093/infdis/jis033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kam YW, Lee WW, Simarmata D, Le Grand R, Tolou H, Merits A, Roques P, Ng LF (2014) Unique epitopes recognized by antibodies induced in chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development. PLoS One 9(4), e95647. doi:10.1371/journal.pone.0095647

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, Gaibani P, Cavrini F, Pierro A, Rossini G, Cameron MJ, Bermejo-Martin JF, Paquette SG, Xu L, Danesh A, Farooqui A, Borghetto I, Kelvin DJ, Sambri V, Rubino S (2011) Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 5(8), e1279. doi:10.1371/journal.pntd.0001279

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kularatne SAM, Weerasinghe SC, Gihan C, Wickramasinghe S, Dharmarathne S, Abeyrathna A, Jayalath T (2012) Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a Hamlet in Sri Lanka, in 2007: A longitudinal cohort study. J Trop Med 2012:639178. doi:10.1155/2012/639178

    Article  PubMed  PubMed Central  Google Scholar 

  • Kumar NP, Suresh A, Vanamail P, Sabesan S, Krishnamoorthy KG, Mathew J, Jose VT, Jambulingam P (2011) Chikungunya virus outbreak in Kerala, India, 2007: a seroprevalence study. Mem Inst Oswaldo Cruz 106(8):912–916

    Article  PubMed  Google Scholar 

  • Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, de Lamballerie X, Suhrbier A, Cherel Y, Le Grand R, Roques P (2010) Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 120(3):894–906. doi:10.1172/JCI40104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Larrieu S, Pouderoux N, Pistone T, Filleul L, Receveur MC, Sissoko D, Ezzedine K, Malvy D (2010) Factors associated with persistence of arthralgia among chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol 47(1):85–88. doi:10.1016/j.jcv.2009.11.014

    Article  PubMed  Google Scholar 

  • Levitt NH, Ramsburg HH, Hasty SE, Repik PM, Cole FE Jr, Lupton HW (1986) Development of an attenuated strain of chikungunya virus for use in vaccine production. Vaccine 4(3):157–162

    Article  CAS  PubMed  Google Scholar 

  • Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, Tarkowski A, van Rooijen N, Fraser RJ, Mahalingam S (2008) Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis 197(11):1585–1593. doi:10.1086/587841

    Article  CAS  PubMed  Google Scholar 

  • Lohachanakul J, Phuklia W, Thannagith M, Thonsakulprasert T, Ubol S (2012) High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand. Microbiol Immunol 56(2):134–138. doi:10.1111/j.1348-0421.2011.00417.x

    Article  CAS  PubMed  Google Scholar 

  • Long KM, Whitmore AC, Ferris MT, Sempowski GD, McGee C, Trollinger B, Gunn B, Heise MT (2013) Dendritic cell immunoreceptor regulates chikungunya virus pathogenesis in mice. J Virol 87(10):5697–5706. doi:10.1128/JVI.01611-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lum FM, Teo TH, Lee WW, Kam YW, Renia L, Ng LF (2013) An essential role of antibodies in the control of chikungunya virus infection. J Immunol 190(12):6295–6302. doi:10.4049/jimmunol.1300304

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Malvy D, Ezzedine K, Mamani-Matsuda M, Autran B, Tolou H, Receveur MC, Pistone T, Rambert J, Moynet D, Mossalayi D (2009) Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis 9:200. doi:10.1186/1471-2334-9-200

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, Sudeep AB, Muruganandam N, Chaitanya IK, Guruprasad DR (2010) Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104(6):392–399. doi:10.1016/j.trstmh.2010.01.011

    Article  PubMed  Google Scholar 

  • Mathew AJ, Goyal V, George E, Thekkemuriyil DV, Jayakumar B, Chopra A, Trivandrum CSG (2011) Rheumatic-musculoskeletal pain and disorders in a naive group of individuals 15 months following a chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract 65(12):1306–1312. doi:10.1111/j.1742-1241.2011.02792.x

    Article  CAS  PubMed  Google Scholar 

  • Messaoudi I, Vomaske J, Totonchy T, Kreklywich CN, Haberthur K, Springgay L, Brien JD, Diamond MS, Defilippis VR, Streblow DN (2013) Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity. PLoS Negl Trop Dis 7(7), e2343. doi:10.1371/journal.pntd.0002343

    Article  PubMed  PubMed Central  Google Scholar 

  • Mohd Zim MA, Sam IC, Omar SF, Chan YF, AbuBakar S, Kamarulzaman A (2013) Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol 56(2):141–145. doi:10.1016/j.jcv.2012.10.019

    Article  CAS  PubMed  Google Scholar 

  • Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Spataro N, Pierro AM, Seyler T, Macini P (2010) Chikungunya virus in North-Eastern Italy: a seroprevalence survey. Am J Trop Med Hyg 82(3):508–511. doi:10.4269/ajtmh.2010.09-0322

    Article  PubMed  PubMed Central  Google Scholar 

  • Moro ML, Grilli E, Corvetta A, Silvi G, Angelini R, Mascella F, Miserocchi F, Sambo P, Finarelli AC, Sambri V, Gagliotti C, Massimiliani E, Mattivi A, Pierro AM, Macini P, Study Group “Infezioni da Chikungunya in E-R” (2012) Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study. J Infect 65(2):165–172. doi:10.1016/j.jinf.2012.04.005

    Article  CAS  PubMed  Google Scholar 

  • Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT (2006) Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 80(2):737–749. doi:10.1128/JVI.80.2.737-749.2006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morrison TE, Fraser RJ, Smith PN, Mahalingam S, Heise MT (2007) Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J Virol 81(10):5132–5143. doi:10.1128/JVI.02799-06

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morrison TE, Simmons JD, Heise MT (2008) Complement receptor 3 promotes severe Ross River virus-induced disease. J Virol 82(22):11263–11272. doi:10.1128/JVI.01352-08

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, Elmore SA, Heise MT (2011) A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am J Pathol 178(1):32–40. doi:10.1016/j.ajpath.2010.11.018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nakaya HI, Gardner J, Poo YS, Major L, Pulendran B, Suhrbier A (2012) Gene profiling of chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheum 64(11):3553–3563. doi:10.1002/art.34631

    Article  CAS  PubMed  Google Scholar 

  • Neighbours LM, Long K, Whitmore AC, Heise MT (2012) Myd88-dependent toll-like receptor 7 signaling mediates protection from severe Ross River virus-induced disease in mice. J Virol 86(19):10675–10685. doi:10.1128/JVI.00601-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ng LF, Chow A, Sun YJ, Kwek DJ, Lim PL, Dimatatac F, Ng LC, Ooi EE, Choo KH, Her Z, Kourilsky P, Leo YS (2009) IL-1beta, IL-6, and RANTES as biomarkers of chikungunya severity. PLoS One 4(1), e4261. doi:10.1371/journal.pone.0004261

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Oertelt-Prigione S (2012) The influence of sex and gender on the immune response. Autoimmun Rev 11(6-7):A479–A485. doi:10.1016/j.autrev.2011.11.022

    Article  CAS  PubMed  Google Scholar 

  • Orr MT, Lanier LL (2010) Natural killer cell education and tolerance. Cell 142(6):847–856. doi:10.1016/j.cell.2010.08.031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger JC, El Amrani M, Yvin JL, Jaffar MC, Frenkiel MP, Sourisseau M, Schwartz O, Butler-Browne G, Despres P, Gessain A, Ceccaldi PE (2007) Human muscle satellite cells as targets of chikungunya virus infection. PLoS One 2(6), e527. doi:10.1371/journal.pone.0000527

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, Lee I, Akahata W, Nabel GJ, Richter MK, Smit JM, Fremont DH, Pierson TC, Heise MT, Diamond MS (2013) Development of a highly protective combination monoclonal antibody therapy against chikungunya virus. PLoS Pathog 9(4), e1003312. doi:10.1371/journal.ppat.1003312

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pal P, Fox J, Hawman DW, Huang Y, Messaoudi I, Kreklywich CN, Denton M, Legasse A, Smith P, Johnson S, Axthelm M, Vanlandingham DL, Streblow D, Higgs S, Morrison TE, Diamond MS (2014) Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable and not purified in mosquitoes. J Virol 88(15):8213–8226

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Panning M, Grywna K, van Esbroeck M, Emmerich P, Drosten C (2008) Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis 14(3):416–422. doi:10.3201/eid1403.070906

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petitdemange C, Becquart P, Wauquier N, Beziat V, Debre P, Leroy EM, Vieillard V (2011) Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog 7(9), e1002268. doi:10.1371/journal.ppat.1002268

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petitdemange C, Wauquier N, Jacquet JM, Theodorou I, Leroy E, Vieillard V (2014) Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by chikungunya or Dengue type-2 viruses. PLoS One 9(9), e108798. doi:10.1371/journal.pone.0108798

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pialoux G, Gaüzère B-A, Jauréguiberry S, Strobel M (2007) Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7(5):319–327. doi:10.1016/s1473-3099(07)70107-x

    Article  PubMed  Google Scholar 

  • Poo YS, Nakaya HI, Gardner J, Larcher T, Schroder WA, Le TT, Major L, Suhrbier A (2014) CCr2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis. J Virol 88(12):6862–6872

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Powers AM, Logue CH (2007) Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 88(Pt 9):2363–2377

    Article  CAS  PubMed  Google Scholar 

  • Powers AM, Brault AC, Tesh RB, Weaver SC (2000) Re-emergence of chikungunya and O’nyong-nyong viruses evidence for distinct geographical lineages and distant evoultionary relationships. J Gen Virol 81:471–479

    Article  CAS  PubMed  Google Scholar 

  • Queyriaux B, Simon F, Grandadam M, Michel R, Tolou H, Boutin JP (2008) Clinical burden of chikungunya virus infection. Lancet Infect Dis 8(1):2–3. doi:10.1016/S1473-3099(07)70294-3

    Article  PubMed  Google Scholar 

  • Ramful D, Carbonnier M, Pasquet M, Bouhmani B, Ghazouani J, Noormahomed T, Beullier G, Attali T, Samperiz S, Fourmaintraux A, Alessandri JL (2007) Mother-to-child transmission of chikungunya virus infection. Pediatr Infect Dis J 26(9):811–815. doi:10.1097/INF.0b013e3180616d4f

    Article  PubMed  Google Scholar 

  • Reddy V, Mani RS, Desai A, Ravi V (2014) Correlation of plasma viral loads and presence of chikungunya IgM antibodies with cytokine/chemokine levels during acute chikungunya virus infection. J Med Virol 86(8):1393–1401. doi:10.1002/jmv.23875

    Article  CAS  PubMed  Google Scholar 

  • Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A (2007) Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370(9602):1840–1846. doi:10.1016/s0140-6736(07)61779-6

    Article  CAS  PubMed  Google Scholar 

  • Robillard P-Y, Boumahni B, Gérardin P, Michault A, Fourmaintraux A, Schuffenecker I, Carbonnier M, Djémili S, Choker G, Roge-Wolter M, Barau G (2006a) Transmission verticale materno-fœtale du virus chikungunya. Presse Med 35(5):785–788. doi:10.1016/s0755-4982(06)74690-5

    Article  PubMed  Google Scholar 

  • Robillard PY, Boumahni B, Gerardin P, Michault A, Fourmaintraux A, Schuffenecker I, Carbonnier M, Djemili S, Choker G, Roge-Wolter M, Barau G (2006b) Vertical maternal fetal transmission of the chikungunya virus. Ten cases among 84 pregnant women. Presse Med 35(5 Pt 1):785–788. doi:10.1016/S0755-4982(06)74690-5

    Google Scholar 

  • Robin S, Ramful D, Le Seach F, Jaffar-Bandjee MC, Rigou G, Alessandri JL (2008) Neurologic manifestations of pediatric chikungunya infection. J Child Neurol 23(9):1028–1035. doi:10.1177/0883073808314151

    Article  PubMed  Google Scholar 

  • Robinson M (1955) An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. Trans R Soc Trop Med Hyg 49(1):28–32

    Article  CAS  PubMed  Google Scholar 

  • Rohatgi A, Corbo JC, Monte K, Higgs S, Vanlandingham DL, Kardon G, Lenschow DJ (2014) Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus. J Virol 88(5):2414–2425. doi:10.1128/JVI.02716-13

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rozen-Gagnon K, Stapleford KA, Mongelli V, Blanc H, Failloux AB, Saleh MC, Vignuzzi M (2014) Alphavirus mutator variants present host-specific defects and attenuation in mammalian and insect models. PLoS Pathog 10(1), e1003877. doi:10.1371/journal.ppat.1003877

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rudd PA, Wilson J, Gardner J, Larcher T, Babarit C, Le TT, Anraku I, Kumagai Y, Loo YM, Gale M Jr, Akira S, Khromykh AA, Suhrbier A (2012) Interferon response factors 3 and 7 protect against chikungunya virus hemorrhagic fever and shock. J Virol 86(18):9888–9898. doi:10.1128/JVI.00956-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rudolph KE, Lessler J, Moloney RM, Kmush B, Cummings DA (2014) Incubation periods of mosquito-borne viral infections: a systematic review. Am J Trop Med Hyg 90(5):882–891. doi:10.4269/ajtmh.13-0403

    Article  PubMed  PubMed Central  Google Scholar 

  • Rulli NE, Guglielmotti A, Mangano G, Rolph MS, Apicella C, Zaid A, Suhrbier A, Mahalingam S (2009) Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis Rheum 60(8):2513–2523. doi:10.1002/art.24682

    Article  CAS  PubMed  Google Scholar 

  • Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S (2011) Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis 204(7):1026–1030. doi:10.1093/infdis/jir470

    Article  CAS  PubMed  Google Scholar 

  • Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML (2010) Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med 207(2):429–442. doi:10.1084/jem.20090851

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schilte C, Buckwalter MR, Laird ME, Diamond MS, Schwartz O, Albert ML (2012) Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to chikungunya infection. J Immunol 188(7):2967–2971. doi:10.4049/jimmunol.1103185

    Article  CAS  PubMed  Google Scholar 

  • Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A (2013) Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 7(3), e2137. doi:10.1371/journal.pntd.0002137

    Article  PubMed  PubMed Central  Google Scholar 

  • Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel MP, Brehin AC, Cubito N, Despres P, Kunst F, Rey FA, Zeller H, Brisse S (2006) Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 3(7), e263

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sharp TM, Roth NM, Torres J, Ryff KR, Perez Rodriguez NM, Mercado C, Pilar Diaz Padro MD, Ramos M, Phillips R, Lozier M, Arriola CS, Johansson M, Hunsperger E, Munoz-Jordan JL, Margolis HS, Garcia BR (2014) Chikungunya cases identified through passive surveillance and household investigations—Puerto Rico, May 5–August 12, 2014. MMWR Morb Mortal Wkly Rep 63(48):1121–1128

    PubMed  Google Scholar 

  • Shrivastava A, Waqar Beg M, Gujrati C, Gopalan N, Rao PV (2011) Management of a vertically transmitted neonatal chikungunya thrombocytopenia. Indian J Pediatr 78(8):1008–1009. doi:10.1007/s12098-011-0371-7

    Article  PubMed  Google Scholar 

  • Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, Dermody TS (2014) A single-amino-acid polymorphism in chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J Virol 88(5):2385–2397. doi:10.1128/JVI.03116-13

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Hance P, Kraemer P, Mohamed A, Lambelliere X, Charrel R, Tolou H (2007) Chikungunya infection an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine 86(3):123–137. doi:10.1097/MD.0b013e31806010a5

    Article  PubMed  Google Scholar 

  • Sissoko D, Moendandze A, Malvy D, Giry C, Ezzedine K, Solet JL, Pierre V (2008) Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One 3(8), e3066. doi:10.1371/journal.pone.0003066

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V (2009) Post-epidemic chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 3(3), e389. doi:10.1371/journal.pntd.0000389

    Article  PubMed  PubMed Central  Google Scholar 

  • Soden M, Vasudevan H, Roberts B, Coelen R, Hamlin G, Vasudevan S, La Brooy J (2000) Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum 43(2):365–369. doi:10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E

    Article  CAS  PubMed  Google Scholar 

  • Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost M-C, Fsihi H, Frenkiel M-P, Blanchet F, Afonso PV, Ceccaldi P-E, Ozden S, Gessain A, Schuffenecker I, Verhasselt B, Zamborlini A, Saïb A, Rey FA, Arenzana-Seisdedos F, Despre P, Michault A, Albert ML, Schwartz O (2007) Characterization of reemerging chikungunya virus. PLoS Pathog 3(6), e89. doi:10.1371/journal.ppat.0030089

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tandale BV, Sathe PS, Arankalle VA, Wadia RS, Kulkarni R, Shah SV, Shah SK, Sheth JK, Sudeep AB, Tripathy AS, Mishra AC (2009) Systemic involvements and fatalities during chikungunya epidemic in India, 2006. J Clin Virol 46(2):145–149. doi:10.1016/j.jcv.2009.06.027

    Article  PubMed  Google Scholar 

  • Teng TS, Foo SS, Simamarta D, Lum FM, Teo TH, Lulla A, Yeo NK, Koh EG, Chow A, Leo YS, Merits A, Chin KC, Ng LF (2012) Viperin restricts chikungunya virus replication and pathology. J Clin Invest 122(12):4447–4460. doi:10.1172/JCI63120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Teo TH, Lum FM, Claser C, Lulla V, Lulla A, Merits A, Renia L, Ng LF (2013) A pathogenic role for CD4+ T cells during chikungunya virus infection in mice. J Immunol 190(1):259–269. doi:10.4049/jimmunol.1202177

    Article  CAS  PubMed  Google Scholar 

  • Thangamani S, Higgs S, Ziegler S, Vanlandingham D, Tesh R, Wikel S (2010) Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. PLoS One 5(8), e12137. doi:10.1371/journal.pone.0012137

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Thiberville SD, Boisson V, Gaudart J, Simon F, Flahault A, de Lamballerie X (2013) Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl Trop Dis 7(1), e2004. doi:10.1371/journal.pntd.0002004

    Article  PubMed  PubMed Central  Google Scholar 

  • Thonnon J, Spiegel A, Diallo M, Diallo A, Fontenille D (1999) Chikungunya virus outbreak in Senegal in 1996 and 1997. Bull Soc Pathol Exot 92(2):79–82

    CAS  PubMed  Google Scholar 

  • Venugopalan A, Ghorpade RP, Chopra A (2014) Cytokines in acute chikungunya. PLoS One 9(10), e111305. doi:10.1371/journal.pone.0111305

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vijayakumar KP, Nair Anish TS, George B, Lawrence T, Muthukkutty SC, Ramachandran R (2011) Clinical profile of chikungunya patients during the epidemic of 2007 in Kerala, India. J Global Infect Dis 3(3):221–226. doi:10.4103/0974-777X.83526

    Article  Google Scholar 

  • Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM (2011) The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis 204(1):115–123. doi:10.1093/infdis/jiq006

    Article  CAS  PubMed  Google Scholar 

  • Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ (2011) ISG15 is critical in the control of chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog 7(10), e1002322. doi:10.1371/journal.ppat.1002322

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Win MK, Chow A, Dimatatac F, Go CJ, Leo YS (2010) Chikungunya fever in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia. J Clin Virol 49(2):111–114. doi:10.1016/j.jcv.2010.07.004

    Article  CAS  PubMed  Google Scholar 

  • Yaseen HM, Simon F, Deparis X, Marimoutou C (2014) Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes. BMC Musculoskelet Disord 15:249. doi:10.1186/1471-2474-15-249

    Article  PubMed  PubMed Central  Google Scholar 

  • Ziegler SA, Lu L, da Rosa AP, Xiao SY, Tesh RB (2008) An animal model for studying the pathogenesis of chikungunya virus infection. Am J Trop Med Hyg 79(1):133–139

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA

    David W. Hawman & Thomas E. Morrison

Authors
  1. David W. Hawman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas E. Morrison
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas E. Morrison .

Editor information

Editors and Affiliations

  1. Department of Microbiology, University of Iowa, Iowa City, Iowa, USA

    Chioma M. Okeoma

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hawman, D.W., Morrison, T.E. (2016). Chikungunya Virus Pathogenesis. In: Okeoma, C. (eds) Chikungunya Virus. Springer, Cham. https://doi.org/10.1007/978-3-319-42958-8_10

Download citation

Publish with us

Policies and ethics

Search

Navigation